Company intelligence / Profile preview
Eutropics Pharmaceuticals
Cambridge, Massachusetts, United Stateseutropics.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Commercial
01
Overview
Eutropics has developed the PraediCare Dx™ platform—a biomarker technology that enables personalized medicine by predicting patient response to cancer therapies. Their BH3 profiling assay provides a functional biomarker for mitochondrial priming in tumor cells and helps guide both standard-of-care and experimental treatments. The company’s lead therapeutic program targets Mcl‑1 with small molecule inhibitors; diagnostic assays are clinically validated for blood cancers such as AML and CLL
- Therapeutic areas
- OncologyHematology
- Modalities
- Small moleculeDiagnostic assay
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with pharmaceutical companies and leading academic cancer centers in the U.S., U.K., and Canada to further develop their platform technology
Beyond the preview
Go deeper on Eutropics Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eutropics Pharmaceuticals.